Burch Richard Alan 13D and 13G filings for Virios Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:16 pm Purchase |
2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI |
Burch Richard Alan | 448,056 2.400% |
2,625 (+0.59%) |
Filing |
| 2022-02-14 09:45 am Purchase |
2021-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
Burch Richard Alan | 445,431 5.200% |
5,250 (+1.19%) |
Filing |
| 2021-02-16 4:44 pm Purchase |
2020-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
Burch Richard Alan | 440,181 5.100% |
440,181 (New Position) |
Filing |